Hirschsprung disease-deafness-polydactyly syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2155OMIM:235740Q43.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hirschsprung disease-deafness-polydactyly syndrome is an extremely rare congenital disorder characterized by the combination of three cardinal features: Hirschsprung disease (aganglionic megacolon), sensorineural deafness, and polydactyly (extra fingers or toes). Hirschsprung disease involves the absence of nerve cells (ganglion cells) in segments of the bowel, leading to severe constipation, bowel obstruction, and abdominal distension typically presenting in the neonatal period. The sensorineural hearing loss affects the inner ear or auditory nerve pathways, and the polydactyly may involve the hands, feet, or both. This syndrome affects multiple body systems including the gastrointestinal tract, the auditory system, and the skeletal system. This condition has been described in only a very small number of families in the medical literature, making it one of the rarest syndromic forms of Hirschsprung disease. The exact genetic basis remains poorly characterized. Some reports have suggested an autosomal recessive inheritance pattern based on the occurrence in siblings born to unaffected parents, though this has not been definitively established. Management is multidisciplinary and symptom-based: Hirschsprung disease typically requires surgical intervention (pull-through procedure) to remove the aganglionic bowel segment, hearing loss may be managed with hearing aids or cochlear implants, and polydactyly can be addressed surgically if functionally or cosmetically indicated. Early diagnosis and coordinated care involving pediatric surgery, audiology, orthopedics, and genetics are essential for optimizing outcomes.

Also known as:

Clinical phenotype terms— hover any for plain English:

Foot polydactylyHP:0001829
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hirschsprung disease-deafness-polydactyly syndrome.

View clinical trials →

No actively recruiting trials found for Hirschsprung disease-deafness-polydactyly syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hirschsprung disease-deafness-polydactyly syndrome community →

No specialists are currently listed for Hirschsprung disease-deafness-polydactyly syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hirschsprung disease-deafness-polydactyly syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hirschsprung disease-deafness-polydactyly syndromeForum →

No community posts yet. Be the first to share your experience with Hirschsprung disease-deafness-polydactyly syndrome.

Start the conversation →

Latest news about Hirschsprung disease-deafness-polydactyly syndrome

No recent news articles for Hirschsprung disease-deafness-polydactyly syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hirschsprung disease-deafness-polydactyly syndrome

What is Hirschsprung disease-deafness-polydactyly syndrome?

Hirschsprung disease-deafness-polydactyly syndrome is an extremely rare congenital disorder characterized by the combination of three cardinal features: Hirschsprung disease (aganglionic megacolon), sensorineural deafness, and polydactyly (extra fingers or toes). Hirschsprung disease involves the absence of nerve cells (ganglion cells) in segments of the bowel, leading to severe constipation, bowel obstruction, and abdominal distension typically presenting in the neonatal period. The sensorineural hearing loss affects the inner ear or auditory nerve pathways, and the polydactyly may involve th

How is Hirschsprung disease-deafness-polydactyly syndrome inherited?

Hirschsprung disease-deafness-polydactyly syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hirschsprung disease-deafness-polydactyly syndrome typically begin?

Typical onset of Hirschsprung disease-deafness-polydactyly syndrome is neonatal. Age of onset can vary across affected individuals.